Related Experiment Video
Updated: Jul 13, 2026

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)
Published on: April 21, 2019
Pay for performance for the allergist-immunologist: potential promise and problems.
Michael Schatz1, Michael Blaiss, George Green
1Department of Allergy, Kaiser Permanente, San Diego, CA 92111, USA. michael.x.schatz@kp.org
Pay for performance programs aim to improve healthcare quality and reduce costs by aligning incentives. While promising, rigorous studies are needed to confirm their effectiveness and monitor for unintended consequences.
Area of Science:
- Health Services Research
- Healthcare Quality Improvement
- Medical Economics
Background:
- Pay for performance (P4P) is a strategy to enhance healthcare quality and cost-efficiency.
- The Physician Consortium for Quality Improvement develops performance measures for P4P initiatives.
- Existing P4P programs face challenges including technical validity, implementation costs, and potential unintended consequences.
Purpose of the Study:
- To review the current landscape of pay for performance in healthcare.
- To highlight concerns and considerations for P4P program development and implementation.
- To emphasize the role of allergist-immunologists in P4P initiatives.
Main Methods:
- Literature review and synthesis of expert opinion on pay for performance.
- Analysis of concerns related to performance measure development and implementation.
- Discussion of recommendations from the Institute of Medicine (2006).
Main Results:
- Evidence supporting P4P effectiveness is emerging but requires more robust research.
- Key concerns include measure validity, risk adjustment, cost, and unintended consequences.
- Careful monitoring is recommended to ensure P4P goals are met and side effects are managed.
Conclusions:
- Pay for performance holds potential for healthcare system improvement.
- Ongoing research and careful implementation monitoring are crucial for P4P success.
- Active participation by allergist-immunologists is vital to advocate for patient and provider interests within P4P frameworks.
Related Concept Videos
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Cross-reactivity
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Allergic Reactions
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

